LB Pharmaceuticals Inc
LBRXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How LB Pharmaceuticals Inc Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 2 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 5, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-06 | KROIN DAVID · 10% owner | Pre-Funded Warrants (Right to Buy) | P — Open market or private purchase | +93,925 | 21.17 | SEC filing |
| 2026-02-06 | KROIN DAVID · 10% owner | Pre-Funded Warrants (Right to Buy) | P — Open market or private purchase | +378,444 | 21.17 | SEC filing |
| 2025-09-12 | Belldegrun Arie · 10% owner | Common Stock | P — Open market or private purchase | +767 | 15.00 | SEC filing |
| 2025-09-12 | KROIN DAVID · 10% owner | Common Stock | P — Open market or private purchase | +2,000,000 | 15.00 | SEC filing |
| 2025-09-12 | Belldegrun Arie · 10% owner | Common Stock | P — Open market or private purchase | +332,566 | 15.00 | SEC filing |
| 2025-09-12 | Pontifax Management 4 G.P. (2015) Ltd. · 10% owner | Common Stock | P — Open market or private purchase | +1,000,000 | 15.00 | SEC filing |
| 2025-09-12 | KROIN DAVID · 10% owner | Common Stock | P — Open market or private purchase | +666,666 | 15.00 | SEC filing |
| 2025-09-12 | Nussbaum Ran · Director | Common Stock | P — Open market or private purchase | +1,000,000 | 15.00 | SEC filing |
Showing 8 of 8 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-03 | Nussbaum Ran · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-06-03 | Luse Rebecca · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-06-03 | RUFFOLO ROBERT R · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-06-03 | Kane William P Jr · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-06-03 | Lenz Robert A. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +12,500 | SEC filing |
| 2026-06-03 | Garland J. Scott · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-06-03 | Hemrajani Rekha · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-03-06 | Lenz Robert A. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +20,000 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-09-10 | Turner Heather D · Chief Executive Officer | Employee Stock Option (Right to Buy) | D — Disposition to the issuer | −175,706 | SEC filing |
| 2025-09-10 | PRENSKY ZACHARY · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −17,929 | SEC filing |
| 2025-09-10 | Eramo Anna · Chief Medical Officer | Employee Stock Option (Right to Buy) | D — Disposition to the issuer | −26,893 | SEC filing |
| 2025-09-10 | PANOFF MARC L · Senior Vice President, Finance | Employee Stock Option (Right to Buy) | D — Disposition to the issuer | −3,944 | SEC filing |
| 2025-09-10 | PANOFF MARC L · Senior Vice President, Finance | Employee Stock Option (Right to Buy) | D — Disposition to the issuer | −1,255 | SEC filing |
| 2025-09-10 | PRENSKY ZACHARY · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −3,944 | SEC filing |
| 2025-09-10 | PRENSKY ZACHARY · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −896 | SEC filing |
| 2025-09-10 | RUFFOLO ROBERT R · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −717 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.